Key result
Valve-in-valve transcatheter pulmonary valve implantation using a modified buddy wire technique successfully treated a degenerated self-expandable valve caused by infective endocarditis, with complete clinical recovery at 12 months.
Why the study?
Infective endocarditis has high mortality in congenital heart disease patients, particularly those with bioprosthetic valves.
Does valve-in-valve TPVI improve symptoms and hemodynamics in a patient with a degenerated self-expandable pulmonary valve due to infective endocarditis?
Case Report (n=1)
Does valve-in-valve TPVI improve symptoms and hemodynamics in a patient with a degenerated self-expandable pulmonary valve due to infective endocarditis?
Valve-in-valve TPVI using a modified buddy wire technique is a feasible and effective treatment for a degenerated self-expandable pulmonary valve caused by infective endocarditis.
Answers are grounded in this paper and cite their sources.
Suggests valve-in-valve TPVI may be viable in select endocarditis cases; leaves open need for prospective studies on durability and generalizability.
Background: Infective endocarditis is a complication with high mortality in patients with congenital heart disease, particularly for those with bioprosthetic valve. Case summary: We report a case of a 54-year-old female with a history of tetralogy of Fallot who had been surgically repaired using a transannular patch due to severe pulmonary insufficiency with right heart enlargement and presented with worsening dyspnea. She had received transcatheter pulmonary valve implantation (TPVI) 5 years ago. Unfortunately, bioprosthesis-associated infective endocarditis occurred due to dental caries. Given persistent antibiotic medication, she became clinically stable with prosthesis functional recovery. However, dysfunctional bioprosthesis was still detected 3 years later, which was successfully treated by valve-in-valve TPVI with the help of modified buddy wire technique. At a 12-month follow-up after valve-in-valve TPVI, she was completely recovered with improved symptoms of heart failure. Conclusion: This is the first report of valve-in-valve TPVI of a self-expandable valve in a degenerated self-expandable valve. The case highlights increased surveillance for infective endocarditis of transcatheter pulmonary valve should be emphasized. Subsequent valve-in-valve TPVI is an effective treatment for valve failure in defined conditions improving the hemodynamics.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) conducted a case report in Deteriorated self-expandable pulmonary valve caused by infective endocarditis (n=1). Valve-in-valve transcatheter pulmonary valve implantation (TPVI) was evaluated on Procedural success and clinical recovery. Valve-in-valve transcatheter pulmonary valve implantation using a modified buddy wire technique successfully treated a degenerated self-expandable valve caused by infective endocarditis, with complete clinical recovery at 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: